Home > Back to Publisher > Report Information

Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery

Kalorama Information
April 1, 2007
118 Pages - SKU: KLI1399450

Abstract Table of Contents Search inside this report Related Reports

New biological treatments are being developed at a record pace, but their potential could be compromised by a significant obstacle: the delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product.

Kalorama's Drug Delivery Markets Series covers these new systems.

The fourth volume of this series, Kalorama's Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery is a complete overview of a delivery mechanism that offers some advantages: low pain, infection risk, fewer side effects and prolonged delivery over time.

Transdermal delivery has the advantage of being able deliver drugs over a long period of time, deliver a substantial amount and do so in a way that causes no pain or discomfort to the patient.

Nicotine patches have lead the growth in this delivery area, and patches are the product most commonly associated with this area, but transdermal delivery includes new transmission methods such as electrotransfer and iontophoresis.

Kalorama's Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery covers the entire market of drugs delivered through the skin or muocus membrane, as well as the delivery technologies. The transdermal/transmucosal drug delivery market is expected to grow steadily with biotechnology drugs that require novel delivery technologies leading this growth. The volume features:

Complete Round-Up of Key Companies
Current Market Size for transdermal and transmucosal segments, as well as the pharmaceutical and technology-only segments
Forecasts to 2011 for Strategic Business Planning
Complete Discussion of Delivery Technologies and how they operate.
Review of Future Products

Market coverage includes both the pharmaceutical products that utilize the drug delivery technology, and drug delivery technology itself.

This market is expected to increase substantially within the forecast period. Additionally, a growing focus on ease of delivery to assist in patient compliance could help drive demand for both transdermal and transmucosal delivery systems.

Chapter One: Executive Summary

Market Drivers
Market Size and Growth
- Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Drug Delivery Only Market
- Competitive and Market Analysis

Chapter Two: Introduction and Overview

Scope and Methodology
Reasons for Transdermal/Transmucosal Drug Delivery Systems
History of Transdermal and Transmucosal Drug Delivery
Phases of Drug Action
Topical Drug Delivery
- Types of Topical Preparations
- Market Participants
- Transdermal Patch Drug Delivery
  - Membrane-Controlled System
  - Adhesive Dispersion-Type System
  - Matrix Diffusion-Controlled System
  - Microreservoir Dissolution-Controlled System
  - New Transdermal Drug Applications and Approvals
  - Electrotransport Drug Delivery
  - Iontophoresis
  - Transmucosal Drug Delivery
    - Oral Transmucosal Fentanyl Citrate (OTFC)
    - Transmucosal Etomidate
    - Ondansetron ODT
    - Buccal Drug Delivery
    - Vaginal Drug Delivery

Chapter three: Trends and Developments

Innovations in Transdermal Drug Delivery
Adhesive Technology and Issues
Adhesive Market Issues
Biotechnological Issues
Iontophoresis and Sonophoresis
Developments in Insulin Delivery
New Developments in Hormone Drug Delivery
New Mucosal/Buccal Delivery Systems
Other New Drug Delivery Systems
Macroflux Technology
Controlled Thermal Energy Technology
New Ultrasound Technology
Combination Delivery Technology
Transdermal Products in Development

Chapter four: Market Size and Growth

The Total Transdermal/Transmucosal Drug Delivery Market
Transdermal/Transmucosal Delivery Technology Only Market

chapter five: Competitive Analysis

Competitive Landscape
Market Analysis

CHAPTER SIX: Company Profiles

3M Pharmaceuticals
Acrux Limited
Altea Therapeutics, Inc
ALZA Corporation
Antares Pharma, Inc.
Aveva Drug Delivery Systems
Cardinal Health
Cephalon Inc
Generex Biotechnology Corporation
Inovio Biomedical Corporation
Labtec GmbH
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)................
MacroChem Corporation
NexMed, Inc.
Noven Pharmaceuticals, Inc.
SkyePharma PLC

Appendix
Company Directory
Table of exhibits
chapter twO: Introduction and Overview

Table 2-1: Sequence of Drug Action

Chapter three: Trends and Developments

Table 3-1: Selected Transdermal Products in Development

Chapter four: Market Size and Growth

Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2002-2010
Figure 4-1.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2002-2010
Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Systems by Type 2002-2010
Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Systems Revenues by Type 2002-2010
Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies Market Share by Type 2002-2010.......
Figure 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies by Type 2006
Figure 4-4: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies by Type 2010
Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
Figure 4-5.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010

chapter five: Competitive Analysis

Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology

Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery

Share this report

Other tasks

Research Assistance

Related Markets

Pharmaceuticals Reports

Free Alert Me service